Arrivent Biopharma shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Arrivent Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Arrivent Biopharma held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Arrivent Biopharma by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $202k | 11k | 18.45 |
| 2025-06-30 | $643k | 30k | 21.77 |
| 2024-12-31 | $218k | 8.2k | 26.64 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas